Der seit Anfang Juli amtierende Vorstandsvorsitzende Michael Grosse übernimmt die vorsichtig gestaltete 1. quantitative 25er Guidance, und das, obgleich das Q2, wie Q1/25, über unseren und den Markt-Erwartungen lag. Q2/25-Konzernumsatz stieg (in CC) mit 5,7 % YoY auf € 884,3 Mio. Das Q2/25-adj.EPS wuchs auf € 1,22 (+6,5 % YoY); das adj. EBITDA (wg. Volumen+ Mix) auf € 264,3 Mio. (+11,5 %; Marge 29,9 %; Vj.: 27,5 %). Der Ausblick werde „zum jetzigen Zeitpunkt“ nicht verändert.
CEO Michael Grosse, who has been in office since the beginning of July, has adopted the cautious Q1/25 guidance, even though Q2, like Q1/25, was above our and the market's expectations. Q2/25 consolidated sales increased (in CC) by 5.7% YoY to € 884.3m. Q2/25 adj. EPS grew to € 1.22 (+6.5% YoY); adj. EBITDA (due to volume + mix) to € 264.3m (+11.5%; margin 29.9%; PY: 27.5%). The outlook will not be changed ‘at the present time’.
Akzo Nobel: FX drives 2Q25 miss and FY guidance cut. dsm-firmenich: Givaudan 1H25 results. Exor: In talks over Iveco sale. Lotus Bakeries: Peer Lindt & Sprüngli 1H25 results. Proximus: CpaaS peer Sinch 2Q25 results hurt by FX. Signify: 2Q25 Preview, challenges ahead. Var Energi: Promising continuation of dividend. Vopak: Continued story. Wereldhave: Strong operational results, positive market tone, guidance raised. Events Calendar
We update the performance of our ING Benelux Favourites list as well as all valuation and ranking tables for our coverage universe. Performance on the front page is dated from the 27 January 2025, while historical performance is included on the second page. The methodology for our favourites selection is based on a bottom-up approach with a focus on absolute performance with clear near-term triggers. It is a rolling list, ie, stocks can enter/exit whenever we think opportune. The ING Benelux Fav...
Overall, the planned revenue and the operating result of the 4th guidance FY 25 are still about 15% behind the average analyst estimate. On July 10, 25, the revenue corridor was made broader and more conservative (organic revenue growth: 0-2% YoY; previously: organic revenue growth: 1-2% YoY). This resulted even in a slight decline in the 25 plan-adjusted EPS.
In Summe steht der Plan-Umsatz und das operative Ergebnis der 4. Guidance FY 25 noch ca. 15 % hinter der mittleren Analystenschätzung zurück. Am 10.07.25 wurde der Umsatzkorridor breiter und konservativer gestaltet (org. Umsatzplus:0-2 % YoY; zuvor: org. Umsatzplus:1-2 % YoY). Mit der Folge eines leichten Rückgangs beim 25er Plan-adj. EPS.
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.